Trial intelligence / Profile preview

Phase Ib Study of Oral Insulin (Capsulin) in Type 2 Diabetes

2006-006251-12Phase 2Completed

Sponsor
Diabetology
Start
Jan 2007
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2, open-label trial of Capsulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Diabetology. Primary endpoint: Change in glucose infusion rate (GIR). Started Jan 2007; status: completed.

02

Drugs

Capsulin
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2006-006251-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-006251-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call